HK1100260A1 - Binding peptidomimetics and uses of the same - Google Patents
Binding peptidomimetics and uses of the sameInfo
- Publication number
- HK1100260A1 HK1100260A1 HK07104723.9A HK07104723A HK1100260A1 HK 1100260 A1 HK1100260 A1 HK 1100260A1 HK 07104723 A HK07104723 A HK 07104723A HK 1100260 A1 HK1100260 A1 HK 1100260A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- monomers
- nucleic acid
- disclosed
- acid molecule
- same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
- C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54622404P | 2004-02-20 | 2004-02-20 | |
PCT/US2005/005383 WO2005081898A2 (fr) | 2004-02-20 | 2005-02-18 | Peptidomimetiques de liaison et utilisations de ceux-ci |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1100260A1 true HK1100260A1 (en) | 2007-09-14 |
Family
ID=34910756
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK07104723.9A HK1100260A1 (en) | 2004-02-20 | 2007-05-03 | Binding peptidomimetics and uses of the same |
Country Status (8)
Country | Link |
---|---|
US (1) | US7906624B2 (fr) |
EP (2) | EP2392586A1 (fr) |
JP (1) | JP2007528725A (fr) |
AT (1) | ATE536367T1 (fr) |
AU (1) | AU2005216126B2 (fr) |
CA (1) | CA2556832A1 (fr) |
HK (1) | HK1100260A1 (fr) |
WO (1) | WO2005081898A2 (fr) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE483466T1 (de) | 2002-05-23 | 2010-10-15 | Univ Pennsylvania | Fas peptid-mimetika und ihre verwendungszwecke |
JP2010526091A (ja) * | 2007-04-30 | 2010-07-29 | インテザイン テクノロジーズ, インコーポレイテッド | 癌の処置のための生物学的な標的基の改変 |
US20100226925A1 (en) * | 2007-09-14 | 2010-09-09 | Amgen Inc. | Homogeneous Antibody Populations |
SG186076A1 (en) | 2010-05-28 | 2013-01-30 | Univ Texas | Oligo-benzamide compounds and their use |
TW201302793A (zh) | 2010-09-03 | 2013-01-16 | Glaxo Group Ltd | 新穎之抗原結合蛋白 |
US8835493B2 (en) | 2011-11-23 | 2014-09-16 | Board Of Regents, The University Of Texas System | Oligo-benzamide compounds for use in treating cancers |
WO2013078277A1 (fr) | 2011-11-23 | 2013-05-30 | The Board Of Regents Of The University Of Texas System | Composés d'oligo-benzamides et leur utilisation dans le traitement de cancers |
AU2015231001A1 (en) | 2014-03-21 | 2016-09-29 | Abbvie Inc. | Anti-EGFR antibodies and antibody drug conjugates |
WO2017015064A1 (fr) * | 2015-07-20 | 2017-01-26 | The Board Of Trustees Of The Leland Stanford Junior University | Phénotypage de détection et quantification de cellules à l'aide d'un réactif de liaison multimère |
BR112018075649A2 (pt) | 2016-06-08 | 2019-04-09 | Abbvie Inc. | anticorpos anti-b7-h3 e conjugados de fármaco de anticorpo |
JP6751165B2 (ja) | 2016-06-08 | 2020-09-02 | アッヴィ・インコーポレイテッド | 抗b7−h3抗体及び抗体薬物コンジュゲート |
CA3027044A1 (fr) | 2016-06-08 | 2017-12-14 | Abbvie Inc. | Anticorps anti-b7-h3 et conjugues anticorps-medicaments |
BR112018075630A2 (pt) | 2016-06-08 | 2019-03-19 | Abbvie Inc. | anticorpos anti-cd98 e conjugados de fármaco de anticorpo |
EP3612567B1 (fr) | 2017-04-19 | 2024-09-11 | Bluefin Biomedicine, Inc. | Anticorps anti-vtcn1 et conjugués anticorps-médicament |
CN107236046B (zh) * | 2017-05-15 | 2021-05-07 | 江苏吴中医药集团有限公司苏州中凯生物制药厂 | 一种重组人内皮抑素融合蛋白及其制备方法和应用 |
CN111278847B (zh) | 2017-07-10 | 2024-04-19 | 斯坦福国际研究院 | 分子导向系统肽及其用途 |
WO2019014199A1 (fr) * | 2017-07-10 | 2019-01-17 | Sri International | Conjugué de saporine peptidique pour le traitement du cancer |
AR124681A1 (es) | 2021-01-20 | 2023-04-26 | Abbvie Inc | Conjugados anticuerpo-fármaco anti-egfr |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5334702A (en) | 1991-03-25 | 1994-08-02 | University Of Illinois | Compositions which are immunologically crossreactive with antibodies and preparative methods therefor |
US5665539A (en) * | 1991-07-12 | 1997-09-09 | The Regents Of The University Of California | Immuno-polymerase chain reaction system for antigen detection |
US5328985A (en) * | 1991-07-12 | 1994-07-12 | The Regents Of The University Of California | Recombinant streptavidin-protein chimeras useful for conjugation of molecules in the immune system |
US6391590B1 (en) * | 1991-10-21 | 2002-05-21 | The Regents Of The University Of California | Recombinant streptavidin-metallothionein chimeric protein having biological recognition specificity |
US5879657A (en) | 1993-03-30 | 1999-03-09 | The Dupont Merck Pharmaceutical Company | Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders |
US6100377A (en) | 1994-06-10 | 2000-08-08 | The Trustees Of The University Of Pennsylvania | Constrained peptides |
US5663144A (en) | 1995-05-03 | 1997-09-02 | The Trustees Of The University Of Pennsylvania | Compounds that bind to p185 and methods of using the same |
US6497881B1 (en) * | 1995-11-30 | 2002-12-24 | New York University | High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein |
WO1997034634A1 (fr) | 1996-03-20 | 1997-09-25 | Sloan-Kettering Institute For Cancer Research | Produits de recombinaison d'anticorps diriges contre le gd2, constitues d'un fragment variable (fv) a chaine simple |
US5922553A (en) * | 1996-11-21 | 1999-07-13 | Trustees Of The University Of Pennsylvania | Method of detecting protein by immuno RNA |
CA2315944A1 (fr) * | 1997-12-24 | 1999-07-08 | Diatech Pty. Ltd. | Molecules bifonctionnelles |
CA2340595A1 (fr) * | 1998-08-25 | 2000-03-02 | University Of Washington | Mutants de streptavidine comportant des domaines fonctionnels secondaires |
US7144991B2 (en) * | 1999-06-07 | 2006-12-05 | Aletheon Pharmaceuticals, Inc. | Streptavidin expressed gene fusions and methods of use thereof |
US6743592B1 (en) * | 2000-07-25 | 2004-06-01 | The Trustees Of The University Of Pennsylvania | Methods, systems and kits for immuno-detection of epitopes expressed on molecules |
US7524628B2 (en) * | 2000-07-25 | 2009-04-28 | The Trustees Of The University Of Pennsylvania | Method for detecting molecules expressing a selected epitope via fluorescent dyes |
US7045286B2 (en) * | 2000-07-25 | 2006-05-16 | The Trustees Of The University Of Pennsylvania | Methods of detecting molecules expressing selected epitopes via fluorescent dyes |
US6998234B2 (en) | 2000-11-03 | 2006-02-14 | Oncotech, Inc. | Methods for cancer prognosis and diagnosis relating to tumor vascular endothelial cells |
US7179785B2 (en) * | 2001-11-21 | 2007-02-20 | The Trustees Of The University Of Pennsylvania | Compounds that bind to p185 and methods of using the same |
-
2005
- 2005-02-18 US US10/589,688 patent/US7906624B2/en not_active Expired - Fee Related
- 2005-02-18 AU AU2005216126A patent/AU2005216126B2/en not_active Ceased
- 2005-02-18 EP EP11172733A patent/EP2392586A1/fr not_active Withdrawn
- 2005-02-18 EP EP05723375A patent/EP1718323B1/fr not_active Not-in-force
- 2005-02-18 AT AT05723375T patent/ATE536367T1/de active
- 2005-02-18 JP JP2006554264A patent/JP2007528725A/ja active Pending
- 2005-02-18 CA CA002556832A patent/CA2556832A1/fr not_active Abandoned
- 2005-02-18 WO PCT/US2005/005383 patent/WO2005081898A2/fr active Application Filing
-
2007
- 2007-05-03 HK HK07104723.9A patent/HK1100260A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2005081898A2 (fr) | 2005-09-09 |
JP2007528725A (ja) | 2007-10-18 |
EP1718323A2 (fr) | 2006-11-08 |
EP1718323B1 (fr) | 2011-12-07 |
AU2005216126A1 (en) | 2005-09-09 |
EP1718323A4 (fr) | 2008-12-31 |
CA2556832A1 (fr) | 2005-09-09 |
EP2392586A1 (fr) | 2011-12-07 |
WO2005081898A3 (fr) | 2006-02-02 |
ATE536367T1 (de) | 2011-12-15 |
US7906624B2 (en) | 2011-03-15 |
AU2005216126B2 (en) | 2011-04-07 |
US20080206136A1 (en) | 2008-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1100260A1 (en) | Binding peptidomimetics and uses of the same | |
Wenzel et al. | Conformational constraints in protein degradation by the 20S proteasome | |
NZ580378A (en) | Recombinant expression vector elements (reves) for enhancing expression of recombinant proteins in host cells | |
HK1092481A1 (en) | Polypeptides having binding affinity for her2 | |
MX357562B (es) | Axmi-115, axmi-113, axmi-005, axmi-163 y axmi-184: proteinas insecticidas vip3a de bacillus thuringiensis y metodos para su uso. | |
PH12013502425A1 (en) | Smoothened polypeptides and methods of use | |
FI3778885T3 (fi) | Muokattujen ihmisen arginaasien koostumuksia ja menetelmiä syövän hoitamiseksi | |
ATE550041T1 (de) | Transglutaminase-vermittelte konjugation von peptiden | |
HK1091217A1 (en) | Tuberculosis vaccine with improved efficacy | |
WO2007018619A3 (fr) | Agents therapeutiques chimeriques | |
AR059300A1 (es) | Peptidos inhibidores de la fusion de vih con propiedades biologicas mejoradas | |
DE602005025141D1 (de) | In Zellen eindringende Peptide als Träger für Moleküle | |
NZ334839A (en) | Polynucleotide molecules encoding neospora proteins and uses thereof | |
EP1842911A4 (fr) | Peptides se liant au hla, fragments d'adn codant pour lesdits peptides et vecteurs recombinants | |
ATE466874T1 (de) | Mit scytovirin der domäne 1 verwandte polypeptide | |
IL174645A0 (en) | MODIFIED cDNA FOR HIGH EXPRESSION LEVELS OF FACTOR VIII AND ITS DERIVATIVES | |
TW200604207A (en) | A superantigen fusion protein and the use thereof | |
WO2010117997A3 (fr) | Ciblage peptidique des cellules de l'oreille interne | |
WO2005058944A3 (fr) | Peptides immunogenes de xage-1 | |
DE10394174D2 (de) | Peptide mit hohem Cysteingehalt | |
EP1221485A3 (fr) | Acides nucléiques codant pour des protéines de Neospora | |
GB0520568D0 (en) | Receptor | |
TH85387B (th) | อินเทอร์เฟอรอน-อัลฟา โพลีเทปไทด์ และคอนจูเกต | |
CO5400145A1 (es) | Proteina asociada con enfermedad | |
MY134618A (en) | Filarial parasite polypeptides and sequences, gene sequences and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20190221 |